GeneDx Holdings Corp. named Mark Gardner, former Senior Vice President at Quest Diagnostics, as President effective June 15, 2026, reporting to CEO Katherine Stueland. The appointment aims to strengthen commercial execution and operational scaling in the rare disease genomics diagnostics market.